Injectable Lipid Emulsions-Advancements, Opportunities and Challenges

被引:173
作者
Hippalgaonkar, Ketan [2 ]
Majumdar, Soumyajit [2 ,3 ]
Kansara, Viral [1 ]
机构
[1] Merck Sharp & Dohme Corp, RNAi Delivery & Proc Dev, Biol & Vaccines, West Point, PA 19486 USA
[2] Univ Mississippi, Dept Pharmaceut, Oxford, MS 38677 USA
[3] Univ Mississippi, Pharmaceut Sci Res Inst, Oxford, MS 38677 USA
来源
AAPS PHARMSCITECH | 2010年 / 11卷 / 04期
关键词
biodisposition; lipid emulsions; microfluidization; parenteral formulations; sterilization; MEDIUM-CHAIN TRIGLYCERIDES; TOTAL PARENTERAL-NUTRITION; OIL-IN-WATER; CHOLESTEROL-RICH MICROEMULSION; CRITICALLY-ILL PATIENTS; DRUG-CARRIER EMULSIONS; FAT EMULSIONS; LIPOPHILIC DRUGS; PHYSICOCHEMICAL PROPERTIES; SUBMICRON EMULSIONS;
D O I
10.1208/s12249-010-9526-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Injectable lipid emulsions, for decades, have been clinically used as an energy source for hospitalized patients by providing essential fatty acids and vitamins. Recent interest in utilizing lipid emulsions for delivering lipid soluble therapeutic agents, intravenously, has been continuously growing due to the biocompatible nature of the lipid-based delivery systems. Advancements in the area of novel lipids (olive oil and fish oil) have opened a new area for future clinical application of lipid-based injectable delivery systems that may provide a better safety profile over traditionally used long- and medium-chain triglycerides to critically ill patients. Formulation components and process parameters play critical role in the success of lipid injectable emulsions as drug delivery vehicles and hence need to be well integrated in the formulation development strategies. Physico-chemical properties of active therapeutic agents significantly impact pharmacokinetics and tissue disposition following intravenous administration of drug-containing lipid emulsion and hence need special attention while selecting such delivery vehicles. In summary, this review provides a broad overview of recent advancements in the field of novel lipids, opportunities for intravenous drug delivery, and challenges associated with injectable lipid emulsions.
引用
收藏
页码:1526 / 1540
页数:15
相关论文
共 159 条
[61]   Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice [J].
Ishida, E ;
Managit, C ;
Kawakami, S ;
Nishikawa, M ;
Yamashita, F ;
Hashida, M .
PHARMACEUTICAL RESEARCH, 2004, 21 (06) :932-939
[62]   Properties of various phospholipid mixtures as emulsifiers or dispersing agents in nanoparticle drug carrier preparations [J].
Ishii, F ;
Nii, T .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2005, 41 (04) :257-262
[63]   EFFECT OF PHOSPHOLIPID EMULSIFIERS ON PHYSICOCHEMICAL PROPERTIES OF INTRAVENOUS FAT EMULSIONS AND OR DRUG CARRIER EMULSIONS [J].
ISHII, F ;
SASAKI, I ;
OGATA, H .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1990, 42 (07) :513-515
[64]   Production of sub-micron emulsions by ultrasound and microfluidization techniques [J].
Jafari, Seid Mahdi ;
He, Yinghe ;
Bhandari, Bhesh .
JOURNAL OF FOOD ENGINEERING, 2007, 82 (04) :478-488
[65]   Preparation and Evaluation of 2-(Allylthio)Pyrazine-Loaded Lipid Emulsion with Enhanced Stability and Liver Targeting [J].
Jang, Jun-Hee ;
Kim, Chong-Kook ;
Choi, Han-Gon ;
Sung, Jung Hoon .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (03) :363-368
[66]  
Jiao J., 2005, Injectable dispersed systems: Formulation, processing, and performance, P77
[67]   Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process [J].
Jumaa, M ;
Müller, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 183 (02) :175-184
[68]   The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions [J].
Jumaa, M ;
Müller, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 163 (1-2) :81-89
[69]   The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant [J].
Jumaa, M ;
Müller, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 174 (1-2) :29-37
[70]   Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate:: evaluation of accelerated and long-term stability [J].
Jumaa, M ;
Müller, BW .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2002, 54 (02) :207-212